Most Planned Parenthood Clinics Are Ineligible for Medicaid Money After Court Ruling
A federal judge issued a preliminary injunction on Monday night that allowed only a fraction of Planned Parenthood health centers to receive Medicaid payments for services like birth control, annual checkups and tests for sexually transmitted diseases. While the judge is open to extending the injunction to cover more clinics, for now most of them are not covered by the order.
Planned Parenthood includes both the national group, Planned Parenthood Federation of America, which advocates for abortion rights and does not provide medical care, and 47 stand-alone nonprofit organizations of varying sizes, called affiliates, that operate health centers according to state and federal laws.
Judge Indira Talwani, of the Federal District Court in Massachusetts, said that in all, 10 affiliates were covered under her injunction, including Planned Parenthood Association of Utah, Planned Parenthood of Delaware, Planned Parenthood Greater Texas, Planned Parenthood Gulf Coast, and Planned Parenthood of Tennessee and North Mississippi.
Planned Parenthood sued the Trump Administration on July 7 over a provision in the new domestic policy law that effectively bars its health clinics from receiving Medicaid payments for any medical services. The same day, the judge issued a 14-day restraining order that allowed virtually all Planned Parenthood affiliates to continue receiving Medicaid payments. That order has expired.
The provision in the law applies to nonprofit health centers that provide abortions, but with a threshold that only Planned Parenthood health centers seem large enough to meet: entities that generated $800,000 or more in revenue from Medicaid payments in the 2023 fiscal year.
Planned Parenthood Federation of America sued on behalf of all of the affiliates, arguing that the federal government had singled them out and punished them for associating with the national advocacy organization. It argued that the domestic policy law is unconstitutional because it violates the affiliates' First Amendments rights.
Judge Talwani ruled on Monday that affiliates like the one in Utah that do not exceed the $800,000 revenue threshold should continue to receive Medicaid funding while the lawsuit makes its way through the courts. And she said that affiliates that are in states where abortion is illegal, and thus do not provide the procedure, should continue to receive Medicaid reimbursements as well.
Both sides in the dispute criticized the judge's ruling. 'We strongly disagree with the court's decision,' said Andrew G. Nixon, a spokesman for the Department of Health and Human Services. 'States should not be forced to fund organizations that have chosen political advocacy over patient care.'
Planned Parenthood Federation of America said in a statement, 'While we're grateful that the court recognized the harm caused by this law, we're disappointed that not all members were granted the necessary relief today.'
It added, 'There will be nothing short of a public health crisis if Planned Parenthood members are allowed to be 'defunded.''
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
BlinkRx Launches "Operation Access Now" to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs
Operation Access Now enables pharmaceutical manufacturers to launch direct‑to‑patient programs within 21 days NEW YORK, August 07, 2025--(BUSINESS WIRE)--BlinkRx, the nation's leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid deployment initiative that enables pharmaceutical manufacturers to build and launch direct-to-patient (DTP) and direct‑to‑business (DTB) channels that expand medication access and deliver pricing transparency in as little as 21 days. This program comes at a moment of growing urgency across the life sciences industry. As traditional access models struggle to meet patient and provider expectations, leading brands are turning to faster, more scalable approaches. BlinkRx's national infrastructure already supports millions of patients across all 50 states. The platform's patient-centric design removes every barrier for patients to start and stay on therapy and delivers significant lift for brands: on average, 52% more patient starts and 41% more fills per patient. With Operation Access Now, the initiative enables: Rapid Stand‑Up: DTP programs that can be operational in as little as 21 days, thanks to BlinkRx's turnkey platform and flexible rules engine. Future-Proof: A modular platform that allows pharmaceutical manufacturers to start with a DTP solution and expand into future capabilities as needs and regulations change. For example, the platform can be deployed for DTB models, and can service both cashpay and insurance patients. Scale: Unique automation capabilities that enable pharmaceutical manufacturers to effortlessly scale based on patient demand and adoption. Legacy DTP solutions, such as copay cards and standalone cash pharmacies, are often costly, inefficient, and prone to patient and physician frustration- causing delays in access, misuse, and poor experiences. BlinkRx's platform addresses these ecosystem issues while ensuring strict regulatory compliance. "Operation Access Now is about removing every barrier between manufacturers and the patients who need their therapies," said Geoffrey Chaiken, Co‑Founder and CEO of BlinkRx. "We're prepared to enable manufacturers to deploy DTP programs and deliver the speed, scale, and flexibility the market demands." About BlinkRx BlinkRx is a Prescription Lifecycle Management Platform that allows the most innovative Life Sciences companies to design every aspect of the prescription journey to unlock branded medication affordability and access for all Americans. Learn more at View source version on Contacts For media inquiries, please contact: Press@
Yahoo
18 minutes ago
- Yahoo
Eli Lilly weight loss pill shows promise in latest clinical trial
Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the drug for approval from the Food and Drug Administration. In a news release Thursday, the drugmaker said the oral medication, called orforglipron, helped adults lose an average of 27.3 pounds in a 72-week trial. The pill showed "significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies," the release added. The results shared by Eli Lilly, which have not been peer reviewed and published as of Thursday morning, are "on par with what we see with the injectable forms of these drugs," Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, said on "CBS Mornings" Thursday. Some investors, however, were disappointed with the results Eli Lilly provided. Shares of the company were down about 13.9% Thursday morning. Also like the injectables, the pill showed some side effects among participants, with the most commonly reported issues being nausea, vomiting, diarrhea and constipation. "About 10% of people who are taking the highest dose, which is also what got you that high level of weight loss ... were unable to continue, had to stop, due to the side effects," Gounder said. Eli Lilly said it is on track to submit orforglipron to regulatory agencies like the FDA for approval later this year, which means it could be available to consumers in 2026, Gounder said. It is unclear how much the drug will cost, but Gounder said she expected it to cost less than injectables. A pill would be a "game changer" in terms of accessibility, she said. "With the injectables, you need needles. You need to be able to refrigerate," she said. "What's great about the pills is it's a lot cheaper to manufacture a pill. It's a lot easier to take, and there are no restrictions around, you have to take it with water, with food. You can take it at any time of day. So this will make it a lot more accessible to people, both in terms of cost as well as convenience." Earlier this year, orforglipron's efficacy and safety was measured in a trial with adults who have Type 2 diabetes, showing positive results. Sneak peek: The Strange Shooting of Alex Pennig Neil deGrasse Tyson weighs in on plans for a moon-based nuclear reactor "Platonic" stars talk about new season and maintaining friendships as adults Solve the daily Crossword
Yahoo
18 minutes ago
- Yahoo
Hillsdale Hospital launches Rural Health Strong to advocate against cuts, changes
Hillsdale Hospital has launched a new campaign, Rural Health Strong, to highlight the significance of rural health services and prompt nationwide action to preserve them, according to a community announcement. It marks the hospital's first new campaign since "Hillsdale Strong. Hillsdale First." — which encouraged the community to utilize local health services. The new campaign was developed in response to Medicaid cuts introduced by the One Big Beautiful Bill Act, along with other regulatory changes and program cancellations that are already affecting rural hospitals, according to the announcement. 'We have to come together and lift our voices,' President and CEO Jeremiah J. Hodshire wrote in the announcement. 'We're financially viable right now, and to sustain that over time, we must be Rural Health Strong. Now is a critical time for us to support and advocate for all rural hospitals — our brothers and sisters around the country.' Rural Health Strong is designed to raise awareness of the value rural hospitals bring to their communities and share the stories of those most affected by legislation that disadvantages them, according to the announcement. 'We encourage anyone touched by rural health to submit photos of what rural health means to them and stories of how rural health has impacted their lives,' wrote Communications and Donor Development Manager Kyrsten Newlon. More: New spinal navigation tech enhances surgeries at Hillsdale Hospital Photos and stories can be sent to marketing@ or submitted at Learn more at This story was created by Janis Reeser, jreeser@ with the assistance of Artificial Intelligence (AI). Journalists were involved in every step of the information gathering, review, editing and publishing process. Learn more at This article originally appeared on Hillsdale Daily News: Hillsdale Hospital launches Rural Health Strong Campaign Solve the daily Crossword
